NIDDK Digital Health Technology for Type 2 Diabetes Management

NIDDK Digital Health Technology for Type 2 Diabetes Management (RFA-DK-26-315) is a focused R01 clinical trial opportunity under NIDDK. It targets digital health approaches for type 2 diabetes management, including continuous glucose monitoring, telemedicine with virtual coaching, connected devices, mobile apps, text messaging, patient portals, and peer-support interventions. NIDDK expects three awards in each of FY2026 and FY2027. Budgets are not capped, but they must match actual need, and the project period can run up to five years. The opportunity is limited to US-based applicants; foreign organizations are not eligible. The strongest applications will read like clinical trials rather than product showcases. Applicants need a design that can test whether a digital intervention improves diabetes management, and the proposal should show a plausible path from the technology to measurable patient benefit. Because the notice is an annual R01 call with a set expiration date, timing and a complete clinical-trial package matter as much as the idea itself.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.